Albumin binding sites studied by high-performance liquid affinity chromatography

International Journal of Pharmaceutics

Volumn 168, Issue 1, 1998, Pages 23-29

  Russeva, Veska N ^a   Zhivkova, Zvetanka D ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Affinity chromatography; Binding sites; Diazepam; Markers; Phenylbutazone; Serum albumin

Indexed keywords

DIAZEPAM; HUMAN SERUM ALBUMIN; PHENYLBUTAZONE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; DRUG BINDING SITE; DRUG COMPETITION; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGAND BINDING; PRIORITY JOURNAL;

EID: 0032496611     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00084-2     Document Type: Article

References (22)

1. Ascoli G., Bertucci C., Salvadori G.F. Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach. J. Pharm. Sci. 84:1995;737-741.
2. Brodersen R., Sjodin T., Sjöholm I. Independent binding of ligands to human serum albumin. J. Biol. Chem. 252:1977;5067-5072.
3. Bruderline H., Bernstein J. An investigation of the L-tryptophan binding sites on serum albumin using cycle analoges and fluorescent probes. J. Biol. Chem. 254:1979;11570-11576.
4. Carter D.C., He X.M., Munson S.H., Twigg P.D., Gernert K.M., Broom M.B., Miller T.Y. Three-dimensional stucture of human serum albumin. Science. 244:1989;1195-1198.
5. Chignell C.F. Optical studies of drug-protein complexes. II. Interaction of phenylbutazone and its analoges with human serum albumin. Mol. Pharmacol. 5:1969;244-252.
6. Domenici E., Bertucci C., Salvadori G.F., Motellier S., Wainer I.W. Immobilized serum albumin: rapid HPLC probe of stereoselective protein binding interactions. Chirality. 2:1990;263-268.
7. Domenici E., Bertucci C., Salvadori P., Wainer I.W. Use of a human serum albumin-based chiral stationary phase for high performance liquid chromatography for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites. J. Pharm. Sci. 80:1991;164-169.
8. Elbary A.A., Vallner J.J., Whitworth C.W. Effect of the albumin conformation on the binding of phenylbutazone and oxyphenbutazone to human serum albumin. J. Pharm. Sci. 71:1982;241-244.
9. Fehske K.J., Muller W.E., Wollert U. The location of drug binding sites in human serum albumin. Biochem. Pharmacol. 30:1981;687-692.
10. Hayball P.J., Holman J.W., Nation R.L. Influence of octanoic acid on the reversible protein binding of ketorolac enantiomers to HSA: comparative LC studies using a HSA chiral stationary phase. J. Chromatogr. B. 662:1994;128-133.
11. He H.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-215.
12. Kurono Y., Ozeki Y., Yamada H., Takeuchi T., Ikeda K. Effects of drug binding on the esterase-like activity of human serum albumin. VII. Subdivision of R-type drugs inhibiting the activity towards p-nitrophenyl acetate. Chem. Pharm. Bull. 35:1987;734-739.
13. Noctor T.A.G., Pham C.D., Kaliszan R., Wainer I.W. Stereochemical aspects of benzodiazepine binding to himan serum albumin. I. Enantioselective high-performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. Mol. Pharmacol. 42:1992;506-511.
14. Noctor T.A.G., Wainer I.W., Hage D.S. Allosteric and competitve displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J. Chromatogr. Biomed. Appl. 577:1992;305-315.
15. Rahim S., Aubry A.-F. Location of binding sites on immobilized human serum albumin for some nonsteroidal anti-inflammatory drugs. J. Pharm. Sci. 84:1995;949-951.
16. Roosdorp N., Wann B., Sjöholm I. Correlation between arginyl residue modification and benzodiazepine binding to human serum albumin. J. Biol. Chem. 252:1977;3876-3880.
17. Rosen A. The measurments of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone. Biochem. Pharmacol. 19:1970;2075-2081.
18. Sjöholm I., Ekman B., Kober A.L., Pahlman I. Seiving B and Sjodin T, Binding of drugs to human serum albumin. XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol. Pharmacol. 16:1979;767-777.
19. Sjöholm, I., 1986. The specificity of drug binding sites on human serum albumin. In: Reidenberg, M.M., Erill, S. (Eds.), Drug-Protein Binding. Praeger, New York, pp. 36-45.
20. 14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 17:1968;143-151.
21. Sudlow G., Birket D.J., Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12:1976;1052-1061.
22. Zhivkova, Z., Russeva, V., 1997. New mathematical approach for evaluation of drug binding to human serum albumin by high-performance liquid affinity chromatography. J. Chromatogr. B, in press.